Copyright © 2000 by the European Society of Cardiology.
Editorial
Patients with ischaemic heart disease and severe left ventricular dysfunction who should not be revascularized?
Unversity Hospital, Uppsala, Sweden
References
- Marwick TH. The viable myocardium: epidemiology, detection, and clinical implications. Lancet. 1998;351:815819[CrossRef][Web of Science][Medline]
- Bonow RO. Identification of the viable myocardium. Circulation. 1996;94:26742680
[Free Full Text] - Bax JJ, Wijns W, Cornel JH. Accuracy of current available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol. 1997;30:14511460[Abstract]
- Pagano D, Townend JN, Littler WA. Coronary artery bypass surgery as treatment for ischemic heart failure: the predictive value of viability assessment with quantitative positron emission tomography for symptomatic and functional outcome. J Thorac Cardiovasc Surg. 1998;115:791799
[Abstract/Free Full Text] - Di Carli MF, Davidsson M, Little R. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol. 1994;73:527533[CrossRef][Web of Science][Medline]
- Marwick TH, Nemec JJ, Lafont A, Salced EE, MacIntyre WJ. Prediction of postexercise fluoro-18-deoxyglucose positron emission tomography of improvement in excercise capacity after revascularization. Am J Cardiol. 1992;69:854859[CrossRef][Web of Science][Medline]
- Meluzin J, Cerny J, Frelich M. Prognostic significance of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. J AM Coll Cardiol. 1998;32:912920
[Abstract/Free Full Text] - Pasquet A, Lauer MS, Williams MJA. Prediction of global left ventricular function after bypass surgery in patients with severe left ventricular dysfunction: impact of preoperative myocardial function, perfusion and metabolism. E Heart J. 2000;21:125136
- Louie HW, Laks H, Milgalter E. Ischemic cardiomyopathy. Criteria for coronary revascularization and cardiac transplantation. Circulation. 1991;84:III-290III-295
- Dreyfus GD, Duboc D, Blasco A. Myocardial viability assesssment in ischemic cardiomyopathy: benefits of coronary revascularization. Ann Thorac Surg. 1994;57:14021408[Abstract]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||